Literature DB >> 9515537

Is radical hepatic surgery safe?

R Brancatisano1, A Isla, N Habib.   

Abstract

BACKGROUND: A prospective review of 200 consecutive liver resections performed for benign and malignant disease, between 1989 and 1995 at the Hammersmith Hospital, was undertaken to evaluate the safety of radical hepatic resection.
METHODS: The indications for operation were: hepatocellular carcinoma (n = 39), cholangiocarcinoma (n = 21), gall bladder carcinoma (n = 8), colorectal secondaries (n = 75), noncolorectal secondaries (n = 35), and benign disease (n = 26). Twenty patients were cirrhotic and 36 were jaundiced. Major resections were performed in 74% of cases and included 63 extended hepatectomies, 17 repeated resections for recurrent colorectal metastases, and 17 resections combined with vascular reconstruction. Total vascular exclusion of the liver was used in the majority of cases.
RESULTS: The overall mortality rate was 5%. Thirty-day mortality was 2.5%. Sepsis and not hemorrhage was the most common cause of death. There were 101 complications that occurred in 37% of the patients. The main complications were subphrenic abscess and biliary leak. The extent of liver resection (major versus minor) significantly increased the risk of morbidity (46% versus 16%). Blood loss greater than 100 mL increased the risk of morbidity from 12% to 25%.
CONCLUSIONS: Major hepatic resection can be achieved with acceptable mortality but high morbidity rates.

Entities:  

Mesh:

Year:  1998        PMID: 9515537     DOI: 10.1016/S0002-9610(97)00265-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Bloodless hepatectomy technique.

Authors:  G Navarra; D Spalding; D Zacharoulis; J P Nicholls; S Kirby; I Costa; N A Habib
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

2.  Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.

Authors:  G Navarra; A Ayav; J-C Weber; S L Jensen; C Smadga; J P Nicholls; N A Habib; L R Jiao
Journal:  Int J Colorectal Dis       Date:  2005-04-28       Impact factor: 2.571

3.  NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy.

Authors:  Hasibur Rehman; Junjiang Sun; Yanjun Shi; Venkat K Ramshesh; Qinlong Liu; Robert T Currin; John J Lemasters; Zhi Zhong
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

4.  Basolateral potassium (IKCa) channel inhibition prevents increased colonic permeability induced by chemical hypoxia.

Authors:  A Loganathan; J E Linley; I Rajput; M Hunter; J P A Lodge; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-21       Impact factor: 4.052

5.  Liver resection without total vascular exclusion: hazardous or beneficial? An analysis of our experience.

Authors:  G Torzilli; M Makuuchi; Y Midorikawa; K Sano; K Inoue; T Takayama; K Kubota
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

6.  Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes.

Authors:  Bernard J DuBray; Kendra D Conzen; Gundumi A Upadhya; Parvathi Balachandran; Jianluo Jia; Brett L Knolhoff; David H Alpers; Thallachallour Mohanakumar; William C Chapman; Christopher D Anderson
Journal:  Surgery       Date:  2012-06-13       Impact factor: 3.982

7.  Population-based review of the outcomes following hepatic resection in a Canadian health region.

Authors:  Elijah Dixon; Oliver F Bathe; Andrew McKay; Isabelle You; Scot Dowden; David Sadler; Kelly W Burak; J Gregory McKinnon; Walter Miller; Francis R Sutherland
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

8.  Total vascular exclusion technique for resection of hepatocellular carcinoma.

Authors:  Zhen-Yu Yin; Xiao-Ming Wang; Ren-Xiang Yu; Bai-Meng Zhang; Ke-Ke Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.